Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his Department's policy is on the recommendations in relation to the provision of information on industry (a) activities, (b) risks, (c) costs and (d) returns on R&D made in the report on Pharmaceutical Innovation and Access to Medicines, published by the OECD in November 2018.
We note the report ‘Pharmaceutical Innovation and Access to Medicines’ published by the Organisation for Economic Co-operation and Development (OECD) in November 2018 and agree with the recommendation that a more informed debate on the cost and benefits of research and development would be beneficial. The OECD’s work through the papers published by the health division of the Directorate of Labour and Social Affairs is a welcome contribution to that debate and we look forward to future publications from them.